MRCS Weekly Recap 22 (6.27.2022 - 7.3.2022)

Updated: Aug 19

1. COVID

Pfizer and BioNTech are starting to plan clinical trials on universal covid vaccine booster shots. These have been studied for a long time but are now being tested in full effect to combat new strains of the virus. FDA advisers are recommending that people get another COVID booster shot for the fall. The FDA panel voted 19-2 in favor of the new booster shots to contain some version of the omicron variant.

2. Policy Updates

As part of the price transparency rule, insurers must list their negotiated rates with in-network providers and the out-of-network allowed amount. Enforcement of the payer version was delayed until July 1, 2922. The price for care will finally be available to all patients giving patients a clearer picture of what insurers and employers will pay for their care.

House lawmakers are looking to allocate over $242 billion to improve public health infrastructure in 2023. The bill would increase the CDC and NIH's funding and increase ARPS-H (research on ALS, Alzheimer's, diabetes, and cancer) by more than $1.75 billion.

0 views0 comments

Recent Posts

See All

1. Amazon Health? Amazon is purchasing One Medical for $3.9 billion in an all-cash deal. This adds a network of brick-and-mortar clinics for Amazon. Amazon is joining other business giants in ad

1. ‘Super Variant’ The Biden administration is extending the public health emergency from the COVID-19 pandemic. The most recent extension was set to expire July 15 but is expected to extend at

1. COVID A new study of Italian healthcare workers shows that 2 or 3 doses of the vaccine (including booster shots) may cut the risk of long-term side effects from covid-19. The odds of long cov